Anti-RAB13 antibody [EPR14110(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal RAB13 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
GIG4, RAB13, Ras-related protein Rab-13, Cell growth-inhibiting gene 4 protein
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
ab205528 was shown to react with RAB13 in wild-type U-87 MG cells in immunocytochemistry with loss of signal observed in a RAB13 siRNA knockdown cell line. Wild-type and siRNA knockdown cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab205528 at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (siRNA knockdown) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and siRNA knockdown cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
- WB
Supplier Data
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
ab205528 was shown to react with RAB13 in wild-type HEK-293T cells in Western blot with loss of signal observed in RAB13 knockout cell line ab266843. Wild-type HEK-293T and RAB13 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hour before incubation with ab205528 overnight at 4 °C at a 1/200 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/200 dilution
Lane 1:
Wild-type HEK-293T lysate at 30 µg
Lane 2:
RAB13 knock-out HEK-293T lysate at 30 µg
false
- WB
Lab
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
Lanes 1-4 : Merged signal (red and green). Green - ab205528 observed at 24 kDa. Red - loading control ab8245 observed at 36 kDa.
ab205528 Anti-RAB13 antibody [EPR14110(2)] was shown to specifically react with RAB13 in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266843 (knockout cell lysate ab258159) was used. Wild-type and RAB13 knockout samples were subjected to SDS-PAGE. ab205528 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
RAB13 knockout HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
Western blot - Human RAB13 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-rab13-knockout-hek-293t-cell-line-ab266843'>ab266843</a>)
Lane 3:
HAP1 whole cell lyate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 23 kDa
Observed band size: 24 kDa
false
- WB
Lab
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
Lanes 1 - 4 : Merged signal (red and green). Green - ab205528 observed at 23 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab205528 was shown to specifically react with RAB13 in wild-type HAP1 cells as signal was lost in RAB13 knockout cells. Wild-type and RAB13 knockout samples were subjected to SDS-PAGE. ab205528 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/2000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/2000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
RAB13 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
HEK293 whole cell lysate at 20 µg
Predicted band size: 23 kDa
false
- WB
Supplier Data
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
ab205528 was shown to react with RAB13 in wild-type U-87 MG cells in Western blot with loss of signal observed in a RAB13 siRNA knockdown cell line. Cell lysates from wild-type U-87 MG transfected with either scrambled siRNA or RAB13 siRNA were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hour before incubation with ab205528 overnight at 4 °C at a 1/200 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/200 dilution
Lane 1:
Wild-type U-87 MG transfected with scrambled siRNA control lysate at 20 µg
Lane 2:
U-87 MG transfected with siRNA specifically targeting RAB13 cell lysate at 20 µg
false
- WB
Supplier Data
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/2000 dilution
Lane 1:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 2:
Caco-2 (Human colorectal adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
A431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-RAB13 antibody [EPR14110(2)] (AB205528)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAB13 antibody [EPR14110(2)] (ab205528) at 1/2000 dilution
All lanes:
Human fetal lung lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-RAB13 antibody [EPR14110(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RAB13 influences cell surface dynamics by controlling the trafficking of proteins to the plasma membrane. It participates in forming complexes with other RAB proteins ensuring precise membrane delivery and recycling. As a result RAB13 assists in cell junction maintenance and tight junction stability enabling proper cell polarization and epithelial barrier function. This function is essential for processes like cell migration and tissue integrity.
Pathways
The role of RAB13 in intracellular trafficking links it to essential biological pathways such as the actin cytoskeleton regulation and the signaling of the epithelial-to-mesenchymal transition (EMT). In the actin regulation pathway RAB13 closely interacts with proteins like RHOA and CDC42 which assist in reorganizing the cytoskeleton essential for cell movement. For the EMT process RAB13 plays a part in modulating the cellular adherence and motility pathways which are critical during development and repair mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Genome biology 19:229 PubMed30591072
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com